Zobrazeno 1 - 10
of 487
pro vyhledávání: '"Theodore E Warkentin"'
Autor:
Steven R Hwang, Yuxiang Wang, Erika L Weil, Anand Padmanabhan, Theodore E Warkentin, Rajiv K Pruthi
Publikováno v:
Platelets, Vol 32, Iss 7, Pp 936-940 (2021)
Spontaneous heparin-induced thrombocytopenia (HIT) syndrome, characterized by clinical and serologic features of HIT despite the absence of proximate heparin exposure, can be triggered by total knee arthroplasty (TKA). A 56-year-old female receiving
Externí odkaz:
https://doaj.org/article/7a048c891e224666b124a62ee750b81d
Publikováno v:
Haematologica, Vol 92, Iss 9 (2007)
Externí odkaz:
https://doaj.org/article/338af9f3ed8447688d9ab82d3197ff88
Autor:
Andreas Koster, Ishac Nazy, Ingvild E. Birschmann, James W. Smith, Jo‐Ann I. Sheppard, Theodore E. Warkentin
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 6, Pp 1060-1064 (2020)
Abstract In a high‐risk patient with subacute heparin‐induced thrombocytopenia (HIT) type A (platelet count recovery following acute HIT but with persisting platelet‐activating antibodies), in whom urgent cardiac surgery was required, a key cli
Externí odkaz:
https://doaj.org/article/231d721a7b0849d5b55483659e328e60
Autor:
Toshiaki Iba, Jerrold H. Levy, Jean Marie Connors, Theodore E. Warkentin, Jecko Thachil, Marcel Levi
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-8 (2020)
Abstract Thrombotic complications and coagulopathy frequently occur in COVID-19. However, the characteristics of COVID-19-associated coagulopathy (CAC) are distinct from those seen with bacterial sepsis-induced coagulopathy (SIC) and disseminated int
Externí odkaz:
https://doaj.org/article/f56f9079ba90414db7bf6ae355c7974c
Autor:
Shuoyan Ning, Nadia Gabarin, Na Li, Yang Liu, Kayla Lucier, Rebecca Barty, Jason Acker, Kathryn E. Webert, Theodore E. Warkentin, Donald M. Arnold, Nancy M. Heddle
Publikováno v:
Transfusion. 63:480-493
Publikováno v:
Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-5 (2018)
Abstract Background Symmetrical peripheral gangrene is characterized as acral (distal extremity) ischemic limb injury affecting two or more extremities, without large vessel obstruction, typically in a symmetrical fashion. Risk factors include hypote
Externí odkaz:
https://doaj.org/article/54c6d238b3a3468983b91ea5194455a0
Autor:
Daniel E. Ezekwudo, Rebecca Chacko, Bolanle Gbadamosi, Syeda Batool, Sussana Gaikazian, Theodore E. Warkentin, Jo-Ann I. Sheppard, Ishmael Jaiyesimi
Publikováno v:
Experimental Hematology & Oncology, Vol 6, Iss 1, Pp 1-8 (2017)
Abstract Background Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening condition caused by the binding of platelet-activating antibodies (IgG) to multimolecular platelet factor 4 (PF4)/heparin complexes because of heparin exposure.
Externí odkaz:
https://doaj.org/article/cfb975602ddd47d0ad11aacfa083ac97
Autor:
Jason B. Giles, Heidi E. Steiner, Jerome Rollin, Christian M. Shaffer, Yukihide Momozawa, Taisei Mushiroda, Chihiro Inai, Kathleen Selleng, Thomas Thiele, Claire Pouplard, Nancy M. Heddle, Michiaki Kubo, Elise C. Miller, Kiana L. Martinez, Elizabeth J. Phillips, Theodore E. Warkentin, Yves Gruel, Andreas Greinacher, Dan M. Roden, Jason H. Karnes
Publikováno v:
Blood Advances. 6:4137-4146
Heparin, a widely used anticoagulant, carries the risk of an antibody-mediated adverse drug reaction, heparin-induced thrombocytopenia (HIT). A subset of heparin-treated patients produces detectable levels of antibodies against complexes of heparin b
Publikováno v:
Rossi's Principles of Transfusion Medicine. :402-423
Publikováno v:
American Journal of Hematology.